Cognex Corporation - CGNX

CGNX Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CGNX	0.9	7.2	8.6	-0.7	-23.2	6.7	-42.4	-32.2	110.2	11327.8
S&P 500	1.0	1.8	-0.9	2.7	7.3	26.5	31.0	80.1	196.5	33856.2

Compare CGNX with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CGNX
name	Cognex Corporation
price	39.73
changes percentage	0.94
change	0.37
day low	39.50
day high	39.97
year high	53.13
year low	34.79
market cap	6814290950
price avg 50	38.60
price avg 200	41.68
exchange	NASDAQ
volume	764910
avg volume	1176483
open	39.97
previous close	39.36
eps	0.51
pe	77.90
earnings announcement	2025-02-13T13:30:00.000+0000
shares outstanding	171515000
timestamp	2025-01-17 21:00:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 28.3%

Overall Quarterly Financial Health: 43.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000851205
revenue	837547000	1006090000	-16.75
gross profit	601241000	721905000	-16.71
gross profit ratio	0.72	0.72	0.05
research and development expenses	139400000	141133000	-1.23
operating expenses	470539000	453240000	3.82
interest income	16047000	6897000	132.67
interest expense	0	16319000	-100.00
ebitda	144582000	288286000	-49.85
ebitdaratio	0.17	0.28	-39.41
operating income	130702000	246229000	-46.92
operating income ratio	0.16	0.24	-36.24
net income	113234000	215525000	-47.46
net income ratio	0.14	0.21	-36.89
eps	0.66	1.24	-46.77

Overall Score of Annual Income Statement

0.12 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 838 million in 2023 from 1,006 million in 2022 representing a change of -16.75%. This indicates a sales growth, which is a positive sign for the company.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 601 million in 2023 from 722 million in 2022 representing a change of -16.71%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 139 million in 2023 from 141 million in 2022 representing a change of -1.23%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 471 million in 2023 from 453 million in 2022 representing a change of 3.82%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 145 million in 2023 from 288 million in 2022 representing a change of -49.85%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 131 million in 2023 from 246 million in 2022 representing a change of -46.92%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 113 million in 2023 from 216 million in 2022 representing a change of -47.46%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.66 in 2023 from 0.66 in 2022 representing a change of -46.77%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000851205
revenue	234742000	239292000	-1.90
gross profit	159399000	166599000	-4.32
gross profit ratio	0.68	0.7	-2.47
research and development expenses	35210000	34962000	0.71
operating expenses	127835000	128142000	-0.24
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	40382000	46377000	-12.93
ebitdaratio	0.17	0.19	-11.24
operating income	31564000	38457000	-17.92
operating income ratio	0.13	0.16	-16.33
net income	29591000	36212000	-18.28
net income ratio	0.13	0.15	-16.70
eps	0.17	0.21	-19.05

Overall Score of Quarterly Income Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 235 million in 2024Q3 from 239 million in 2024Q2 representing a change of -1.9%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 159 million in 2024Q3 from 167 million in 2024Q2 representing a change of -4.32%. This indicates a sales profitability decline, which is a negative sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 40 million in 2024Q3 from 46 million in 2024Q2 representing a change of -12.93%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 32 million in 2024Q3 from 38 million in 2024Q2 representing a change of -17.92%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 30 million in 2024Q3 from 36 million in 2024Q2 representing a change of -18.28%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.17 in 2024Q3 from 0.17 in 2024Q2 representing a change of -19.05%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 35 million in 2024Q3 from 35 million in 2024Q2 representing a change of 0.71%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 128 million in 2024Q3 from 128 million in 2024Q2 representing a change of -0.24%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000851205
total assets	2017812000	1958140000	3.05
total liabilities	513060000	519746000	-1.29
total equity	1504752000	1438394000	4.61
cash and cash equivalents	202655000	854250000	-76.28
short term investments	129392000	218759000	-40.85
long term investments	244230000	454117000	-46.22
total current assets	678997000	1102147000	-38.39
total non current assets	1338815000	855993000	56.40
total current liabilities	151884000	228128000	-33.42
total non current liabilities	361176000	291618000	23.85
common stock	343000	345000	-0.58
retained earnings	512543000	528179000	-2.96
total debt	78601000	48206000	63.05

Overall Score of Annual Balance Sheet

0.4 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 2,018 million in 2023 from 1,958 million in 2022 representing a change of 3.05%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 513 million in 2023 from 520 million in 2022 representing a change of -1.29%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 1,505 million in 2023 from 1,438 million in 2022 representing a change of 4.61%. This indicates an increase in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities decreased to 152 million in 2023 from 228 million in 2022 representing a change of -33.42%. This indicates a lower short-term debt burden.

• 📉 Negative Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 203 million in 2023 from 854 million in 2022 representing a change of -76.28%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 129 million in 2023 from 219 million in 2022 representing a change of -40.85%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 679 million in 2023 from 1,102 million in 2022 representing a change of -38.39%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 0 in 2023 from 0 in 2022 representing a change of -0.58%. This indicates a decrease in ownership interest.

  Retained Earnings: Retained Earnings decreased to 513 million in 2023 from 528 million in 2022 representing a change of -2.96%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 79 million in 2023 from 48 million in 2022 representing a change of 63.05%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000851205
total assets	2063247000	2004084000	2.95
total liabilities	496221000	497354000	-0.23
total equity	1567026000	1506730000	4.00
cash and cash equivalents	197075000	176626000	11.58
short term investments	90803000	112449000	-19.25
long term investments	319287000	266214000	19.94
total current assets	672082000	669707000	0.35
total non current assets	1391165000	1334377000	4.26
total current liabilities	170736000	168783000	1.16
total non current liabilities	325485000	328571000	-0.94
common stock	343000	343000	0.00
retained earnings	527909000	515142000	2.48
total debt	77181000	74183000	4.04

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 2,063 million in 2024Q3 from 2,004 million in 2024Q2 representing a change of 2.95%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 496 million in 2024Q3 from 497 million in 2024Q2 representing a change of -0.23%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 1,567 million in 2024Q3 from 1,507 million in 2024Q2 representing a change of 4.0%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 197 million in 2024Q3 from 177 million in 2024Q2 representing a change of 11.58%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 672 million in 2024Q3 from 670 million in 2024Q2 representing a change of 0.35%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 528 million in 2024Q3 from 515 million in 2024Q2 representing a change of 2.48%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 91 million in 2024Q3 from 112 million in 2024Q2 representing a change of -19.25%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 171 million in 2024Q3 from 169 million in 2024Q2 representing a change of 1.16%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 77 million in 2024Q3 from 74 million in 2024Q2 representing a change of 4.04%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000851205
net change in cash	21281000	-4787000	544.56
operating cash flow	112916000	243406000	-53.61
free cash flow	89839000	223739000	-59.85
capital expenditure	-23077000	-19667000	-17.34
depreciation and amortization	21880000	19621000	11.51
deferred income tax	-19779000	-27338000	27.65
stock based compensation	54768000	54505000	0.48
accounts payables	-13744000	-17277000	20.45
inventory	3775000	-48934000	107.71
acquisitions net	-257056000	-5050000	-4,990.22
investments in property plant and equipment	-23077000	-19667000	-17.34
net cash used for investing activites	32273000	-4454000	824.58
debt repayment	0	0	NaN
common stock issued	0	9861000	-100.00
common stock repurchased	-79794000	-204314000	60.95
dividends paid	-49079000	-45921000	-6.88
net cash used provided by financing activities	-125605000	-240374000	47.75
cash at end of period	202655000	181374000	11.73
accounts receivables	23091000	3454000	568.53
cash at beginning of period	181374000	186161000	-2.57

Overall Score of Annual Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 21 million in 2023 from -5 million in 2022 representing a change of 544.56%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -23 million in 2023 from -20 million in 2022 representing a change of -17.34%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 14 million in 2023 from 17 million in 2022 representing a change of 20.45%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 113 million in 2023 from 243 million in 2022 representing a change of -53.61%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 90 million in 2023 from 224 million in 2022 representing a change of -59.85%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to -20 million in 2023 from -27 million in 2022 representing a change of 27.65%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 55 million in 2023 from 55 million in 2022 representing a change of 0.48%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 23 in 2023 from 3 million in 2022 representing a change of 568.53%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -49 million in 2023 from -46 million in 2022 representing a change of -6.88%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000851205
operating cash flow	56271000	27763000	102.68
free cash flow	51872000	23253000	123.08
capital expenditure	-4399000	-4510000	2.46
depreciation and amortization	8818000	7920000	11.34
deferred income tax	-5902000	-4205000	-40.36
stock based compensation	13101000	12964000	1.06
accounts receivables	3886000	-21241000	118.29
accounts payables	6781000	-4612000	247.03
inventory	2279000	12083000	-81.14
acquisitions net	0	-450000	100.00
investments in property plant and equipment	-4399000	-4510000	2.46
net cash used for investing activites	-27409000	35238000	-177.78
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-3962000	-10540000	62.41
dividends paid	-12863000	-12868000	0.04
net cash used provided by financing activities	-15159000	-22418000	32.38
net change in cash	20449000	37767000	-45.85
cash at end of period	197075000	176626000	11.58
cash at beginning of period	176626000	138859000	27.20

Overall Score of Quarterly Cashflow Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 20 million in 2024Q3 from 38 million in 2024Q2 representing a change of -45.85%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -4 million in 2024Q3 from -5 million in 2024Q2 representing a change of 2.46%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 13 million in 2024Q3 from 13 million in 2024Q2 representing a change of 1.06%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 7 million in 2024Q3 from 5 million in 2024Q2 representing a change of 247.03%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 4 in 2024Q3 from -21 million in 2024Q2 representing a change of 118.29%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 56 million in 2024Q3 from 28 million in 2024Q2 representing a change of 102.68%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 52 million in 2024Q3 from 23 million in 2024Q2 representing a change of 123.08%. This indicates an increase in cash generated after accounting for capital expenditures.

  Dividends Paid: Dividends Paid increased to -13 million in 2024Q3 from -13 million in 2024Q2 representing a change of 0.04%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	4.86	5.8	-16.19
net income per share	0.66	1.24	-47.11
operating cash flow per share	0.66	1.4	-53.30
free cash flow per share	0.52	1.29	-59.58
cash per share	1.93	6.19	-68.85
book value per share	8.74	8.29	5.32
tangible book value per share	5.8	6.82	-15.04
shareholders equity per share	8.74	8.29	5.32
interest debt per share	0.46	0.37	22.63
market cap	7189673260	8169203770	-11.99
enterprise value	7065619260	7363159770	-4.04
pe ratio	63.49	37.9	67.51
price to sales ratio	8.58	8.12	5.72
pocfratio	63.67	33.56	89.72
pfcf ratio	80.03	36.51	119.18
pb ratio	4.78	5.68	-15.87
ptb ratio	4.78	5.68	-15.87
ev to sales	8.44	7.32	15.27
enterprise value over ebitda	48.87	25.54	91.34
ev to operating cash flow	62.57	30.25	106.85
ev to free cash flow	78.65	32.91	138.98
earnings yield	0.02	0.03	-40.30
free cash flow yield	0.01	0.03	-54.38
debt to equity	0.05	0.03	55.86
debt to assets	0.04	0.02	58.23
net debt to ebitda	-0.86	-2.8	69.31
current ratio	4.47	4.83	-7.47
interest coverage	0	15.09	-100.00
income quality	1.0	1.13	-11.70
dividend yield	0.01	0.01	21.44
payout ratio	0.43	0.21	103.43
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.17	0.14	18.65
intangibles to total assets	0.25	0.13	92.58
capex to operating cash flow	0.2	0.08	152.94
capex to revenue	0.03	0.02	40.95
capex to depreciation	1.05	1.0	5.22
stock based compensation to revenue	0.07	0.05	20.70
graham number	11.37	15.23	-25.36
roic	0.06	0.12	-52.13
return on tangible assets	0.07	0.13	-40.81
graham net net	-0.07	4.1	-101.76
working capital	527113000	874019000	-39.69
tangible asset value	998619000	1183350000	-15.61
net current asset value	165937000	582401000	-71.51
invested capital	1214210000	1246459000	-2.59
average receivables	122081000	130967000	-6.78
average payables	24278500	35577000	-31.76
average inventory	142382500	117791000	20.88
days sales outstanding	50.8	46.29	9.74
days payables outstanding	33.14	34.81	-4.80
days of inventory on hand	250.67	157.31	59.35
receivables turnover	7.19	7.88	-8.88
payables turnover	11.01	10.49	5.05
inventory turnover	1.46	2.32	-37.24
roe	0.08	0.15	-49.78
capex per share	0.13	0.11	18.13

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 63.49 on 2023-12-31 from 37.90 on 2022-12-31, representing a change of 67.51%. Indicating an increase in the relative valuation of the company's stock.

• Negative

  Current Ratio: Current Ratio decreased to 4.47 on 2023-12-31 from 4.83 on 2022-12-31, representing a change of -7.47%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.05 on 2023-12-31 from 0.03 on 2022-12-31, representing a change of 55.86%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-29 Q3	2024-06-30 Q2	Q/Q change %
CGNX
calendar year	2024	2024	NaN
revenue per share	1.37	1.39	-1.87
net income per share	0.17	0.21	-18.26
operating cash flow per share	0.33	0.16	102.74
free cash flow per share	0.3	0.14	123.14
cash per share	1.68	1.68	-0.39
book value per share	9.14	8.78	4.03
tangible book value per share	6.25	5.99	4.48
shareholders equity per share	9.14	8.78	4.03
interest debt per share	0.45	0.43	4.07
market cap	6946519500	7960755200	-12.74
enterprise value	6826625500	7858312200	-13.13
pe ratio	58.69	54.96	6.78
price to sales ratio	29.59	33.27	-11.05
pocfratio	123.45	286.74	-56.95
pfcf ratio	133.92	342.35	-60.88
pb ratio	4.43	5.28	-16.10
ptb ratio	4.43	5.28	-16.10
ev to sales	29.08	32.84	-11.44
enterprise value over ebitda	169.05	169.44	-0.23
ev to operating cash flow	121.32	283.05	-57.14
ev to free cash flow	131.61	337.95	-61.06
earnings yield	0.0	0.0	-6.35
free cash flow yield	0.01	0.0	155.65
debt to equity	0.05	0.05	0.04
debt to assets	0.04	0.04	1.06
net debt to ebitda	-2.97	-2.21	-34.41
current ratio	3.94	3.97	-0.79
interest coverage	0	0	NaN
income quality	1.9	0.77	148.03
dividend yield	0.0	0.0	14.56
payout ratio	0.43	0.36	22.33
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.15	0.15	2.66
intangibles to total assets	0.24	0.24	0.10
capex to operating cash flow	0.08	0.16	-51.88
capex to revenue	0.02	0.02	-0.57
capex to depreciation	0.5	0.57	-12.39
stock based compensation to revenue	0.06	0.05	3.02
graham number	5.96	6.46	-7.79
roic	0.01	0.02	-26.05
return on tangible assets	0.02	0.02	-20.60
graham net net	-0.06	-0.05	-21.23
working capital	501346000	500924000	0.08
tangible asset value	1072803000	1027140000	4.45
net current asset value	175861000	172353000	2.04
invested capital	1171179000	1154794000	1.42
average receivables	160624000	151228000	6.21
average payables	26300500	25038000	5.04
average inventory	156266500	164063000	-4.75
days sales outstanding	61.38	60.61	1.26
days payables outstanding	35.82	28.0	27.91
days of inventory on hand	185.49	194.69	-4.73
receivables turnover	1.47	1.48	-1.24
payables turnover	2.51	3.21	-21.82
inventory turnover	0.49	0.46	4.97
roe	0.02	0.02	-21.43
capex per share	0.03	0.03	-2.43

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-29 Q3 from 0.02 on 2024-06-30 Q2, representing a change of -21.43%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 3.94 on 2024-09-29 Q3 from 3.97 on 2024-06-30 Q2, representing a change of -0.79%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 58.69 on 2024-09-29 Q3 from 54.96 on 2024-06-30 Q2, representing a change of 6.78%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.05 on 2024-09-29 Q3 from 0.05 on 2024-06-30 Q2, representing a change of 0.04%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 19.14 which is lower than current price 39.73, indicates the company may be overvalued.